As an industry, we welcome the publication of the Commission’s Industrial Strategy and look forward to the release of the roadmap for the upcoming Pharmaceutical Strategy. Both bring the future of Europe’s life sciences sector into sharp focus and both represent a unique opportunity to work together to reestablish Europe’s global leadership in medical innovation while ensuring access to new treatments and technologies today. 

EFPIA has outlined steps that we believe that Europe can and should take and we look forward to engaging with all stakeholders in the coming months to realise our region’s potential for the benefit of today and tomorrow’s patients. The time is now.